TG Therapeutics

+$2.52 (+7.39%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.

CEO
Michael Sean Weiss
Employees
272
Headquarters
New York, New York
Founded
1993

TGTX Key Statistics

Market Cap
5.46B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
829.24K
High Today
$36.80
Low Today
$34.39
Open Price
$34.59
Volume
719.46K
52 Week High
$56.74
52 Week Low
$17.67

TGTX Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure